Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.
Kandzari DE, Colombo A, Park SJ, Tommaso CL, Ellis SG, Guzman LA, Teirstein PS, Tamburino C, Ormiston J, Stone GW, Dangas GD, Popma JJ, Bass TA; American College of Cardiology Interventional Scientific Council. Kandzari DE, et al. Among authors: ormiston j. J Am Coll Cardiol. 2009 Oct 20;54(17):1576-88. doi: 10.1016/j.jacc.2009.07.021. J Am Coll Cardiol. 2009. PMID: 19833256 Free article.
Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials.
Stone GW, Abizaid A, Onuma Y, Seth A, Gao R, Ormiston J, Kimura T, Chevalier B, Ben-Yehuda O, Dressler O, McAndrew T, Ellis SG, Kereiakes DJ, Serruys PW. Stone GW, et al. Among authors: ormiston j. J Am Coll Cardiol. 2017 Dec 12;70(23):2863-2874. doi: 10.1016/j.jacc.2017.09.1106. Epub 2017 Oct 31. J Am Coll Cardiol. 2017. PMID: 29100704 Free article. Clinical Trial.
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW. Doi H, et al. Among authors: ormiston ja. JACC Cardiovasc Interv. 2009 Dec;2(12):1269-75. doi: 10.1016/j.jcin.2009.10.005. JACC Cardiovasc Interv. 2009. PMID: 20129555 Free article.
Coronary balloon angioplasty, stents, and scaffolds.
Byrne RA, Stone GW, Ormiston J, Kastrati A. Byrne RA, et al. Among authors: ormiston j. Lancet. 2017 Aug 19;390(10096):781-792. doi: 10.1016/S0140-6736(17)31927-X. Lancet. 2017. PMID: 28831994 Review.
Long-term paclitaxel-eluting stent outcomes in elderly patients.
Forman DE, Cox DA, Ellis SG, Lasala JM, Ormiston JA, Stone GW, Turco MA, Wei JY, Joshi AA, Dawkins KD, Baim DS. Forman DE, et al. Circ Cardiovasc Interv. 2009 Jun;2(3):178-87. doi: 10.1161/CIRCINTERVENTIONS.109.855221. Epub 2009 Jun 2. Circ Cardiovasc Interv. 2009. PMID: 20031714
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.
Turco MA, Ormiston JA, Popma JJ, Mandinov L, O'Shaughnessy CD, Mann T, McGarry TF, Wu CJ, Chan C, Webster MW, Hall JJ, Mishkel GJ, Cannon LA, Baim DS, Koglin J. Turco MA, et al. Among authors: ormiston ja. J Am Coll Cardiol. 2007 Apr 24;49(16):1676-83. doi: 10.1016/j.jacc.2007.01.069. Epub 2007 Apr 6. J Am Coll Cardiol. 2007. PMID: 17448368 Free article. Clinical Trial.
The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.
Uchida T, Popma J, Stone GW, Ellis SG, Turco MA, Ormiston JA, Muramatsu T, Nakamura M, Nanto S, Yokoi H, Baim DS. Uchida T, et al. Among authors: ormiston ja. JACC Cardiovasc Interv. 2010 Apr;3(4):403-11. doi: 10.1016/j.jcin.2010.01.010. JACC Cardiovasc Interv. 2010. PMID: 20398868 Free article.
257 results